Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q1 2024 vs. Q4 2023
How the institutions holding Fortress Biotech, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 42 | 1 | 40 | −1 |
| Shares | 4.68M | 131.5K | 2.93M | −1.62M (−35.6%) |
| Value | $14.1M | $395.8K | $5.61M | −$8.09M (−59.0%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 107,276 | $215.0K | 0.02% |
| MYDA Advisors LLC | 37,000 | $74.0K | 0.03% |
| Financial Advocates Investment Management | 22,039 | $44.1K | 0.00% |
| PFG Investments, LLC | 16,291 | $32.6K | 0.00% |
| Virtu Financial LLC | 15,310 | $31.0K | 0.00% |
| UBS Group AG | 3,775 | $7.55K | 0.00% |
| BNP Paribas Arbitrage, SA | 376 | $752 | 0.00% |
| Pathway Financial Advisers, LLC | 250 | $500 | 0.00% |
Sold out (9)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| CVI Holdings, LLC | 764,549 | $2.30M |
| Armistice Capital, LLC | 596,000 | $1.79M |
| Altium Capital Management LP | 405,122 | $1.22M |
| Hudson Bay Capital Management LP | 327,235 | $985.0K |
| Jane Street Group, LLC | 28,159 | $84.8K |
| Renaissance Technologies LLC | 25,867 | $78.0K |
| Wealth Management Partners, LLC | 20,000 | $60.2K |
| Simplex Trading, LLC | 1,762 | $5.00K |
| Tower Research Capital LLC (TRC) | 198 | $596 |
Not filed for Q1 2024 yet (1)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| PVG Asset Management Corp | 131,490 | $395.8K |